Anticoagulant treatment of venous thromboembolism.
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003374:Coumarins / Q000494:pharmacology / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007192:Indenes / Q000494:pharmacology / Q000627:therapeutic use; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007866:Leg / Q000098:blood supply; D011517:Prothrombin Time; D011655:Pulmonary Embolism / Q000150:complications; D012008:Recurrence; D013923:Thromboembolism / Q000150:complications / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D000925:Anticoagulants; D003374:Coumarins; D007192:Indenes; D014812:Vitamin K; D006493:Heparin